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Abstract
During acute bacterial infections such as meningitis, neutrophils enter the tissue where they combat the infection before
they undergo apoptosis and are taken up by macrophages. Neutrophils show pro-inflammatory activity and may contribute
to tissue damage. In pneumococcal meningitis, neuronal damage despite adequate chemotherapy is a frequent clinical
finding. This damage may be due to excessive neutrophil activity. We here show that transgenic expression of Bcl-2 in
haematopoietic cells blocks the resolution of inflammation following antibiotic therapy in a mouse model of pneumococcal
meningitis. The persistence of neutrophil brain infiltrates was accompanied by high levels of IL-1b and G-CSF as well as
reduced levels of anti-inflammatory TGF-b. Significantly, Bcl-2-transgenic mice developed more severe disease that was
dependent on neutrophils, characterized by pronounced vasogenic edema, vasculitis, brain haemorrhages and higher
clinical scores. In vitro analysis of neutrophils demonstrated that apoptosis inhibition completely preserves neutrophil
effector function and prevents internalization by macrophages. The inhibitor of cyclin-dependent kinases, roscovitine
induced apoptosis in neutrophils in vitro and in vivo. In wild type mice treated with antibiotics, roscovitine significantly
improved the resolution of the inflammation after pneumococcal infection and accelerated recovery. These results indicate
that apoptosis is essential to turn off activated neutrophils and show that inflammatory activity and disease severity in a
pyogenic infection can be modulated by targeting the apoptotic pathway in neutrophils.
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Introduction
The coordinated termination of immune responses is critical to
prevent autoimmunity and immunopathology, and the varying
effector systems of the immune response are likely to require
different ways for their termination. Against bacterial and fungal
infections, the first line of defence is formed by neutrophils. In
acute infections, there is typically a rapid influx of neutrophils from
the blood into the site of infection, which is often followed by the
infiltration of monocytes that then differentiate into inflammatory
macrophages [1].
Neutrophil tissue invasion can be triggered by infection or
injury and is mediated especially by lipid chemoattractants such as
leukotrienes (for a recent review see [2]). The removal of
neutrophils in the resolution phase occurs through neutrophil
apoptosis and phagocytic uptake by inflammatory macrophages
[3]. As neutrophils contain or can generate a number of toxic
substances and intermediates, it is considered critical that they die
by apoptosis, since in the course of apoptotic cell death the plasma
membrane stays intact until the dying cell has been ingested by a
macrophage [3,4].
Severe infections with pyogenic bacteria cause a massive influx
of neutrophils and strong signs of inflammation and can lead to
permanent tissue damage at the site of infection. Human
pneumococcal meningitis is a frequent and problematic infectious
disease, not only because of its high lethality but also because
patients, despite rapid and optimal antibiotic treatment often are
left with neurological deficits as a consequence of brain tissue
damage [5]. It has been speculated in the past, and circumstantial
evidence has been provided for this [6,7], that the neutrophil-
dominated inflammatory response contributes to this outcome in
pneumococcal meningitis.
Neutrophils in circulation are extremely short-lived before they
undergo apoptosis and are taken up by macrophages [8]. A number
of interleukins and other signals have been identified that can
extend the lifespan of neutrophils and that probably operate to keep
them alive in the inflammatory environment for long enough to be
effective at combating bacteria [9,10]. In a model of non-infectious,
carrageenan-induced pleurisy in rats, experimental enhancement of
apoptosis in neutrophils was able to reduce the number of
inflammatory cells while a peptide that delayed neutrophil apoptosis
was able to enhance inflammatory cell number [11] indicating that
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in sterile inflammation apoptosis regulates the number of
inflammatory cells. A recent report further demonstrates that
experimental induction of apoptosis in models of non-infectious
inflammation can enhance resolution of the process [12]. These
results suggest that neutrophil presence indeed can regulate
inflammation in these cases and indicate the possibility that the
level of apoptosis may also determine the clinical outcome of
pyogenic infections upon antibiotic treatment (i. e. when the
infectious agent has been cleared away therapeutically).
Neutrophils are said to ‘age’ before undergoing programmed
cell death. It is not clear, however, whether ageing is the
expression of an independent molecular program in neutrophils
or is simply the state close to physiological apoptosis. Mouse
neutrophils over-expressing transgenic Bcl-2 or lacking the pro-
apoptotic Bcl-2 protein Bim show strongly reduced spontaneous
apoptosis [13,14]. These results indicate that the activation of Bim
initiates spontaneous neutrophil apoptosis while high-level expres-
sion of Bcl-2 can block this process.
We here test how neutrophil apoptosis affects inflammation and
disease severity in experimental meningitis. When neutrophils
were kept alive by Bcl-2 in transgenic mice, the inflammation was
exacerbated, which indicates that neutrophils that were kept
experimentally alive were able to maintain their pro-inflammatory
activity. This was corroborated by in vitro analyses that show that
such ‘undead’ cells are indeed fully competent functionally. We
finally used the drug roscovitine to induce apoptosis in wt
neutrophils in vivo. This treatment substantially improved recovery
of antibiotics-treated mice. In the resolution of a pyogenic
infection, inflammation (and tissue damage) is thus determined
by the lifespan of neutrophils, and therapeutic targeting of the
apoptotic pathway can modulate the clinical outcome.
Results
Inhibition of apoptosis by Bcl-2 maintains inflammation
in vivo in experimental meningitis
Bacterial, especially pyogenic infections are dominated by the
influx of neutrophils which, at the end of the infection, die and are
taken up by macrophages. A reduction in physiological apoptosis
might result in prolonged neutrophil presence at the site of
inflammation. Because of their capacity for the production of toxic
mediators, this continued neutrophil presence could result in
hyperinflammatory tissue damage. We tested this hypothesis in a
model of mouse pneumococcal meningitis. In this model,
pneumococci are directly inoculated into the cerebrospinal fluid
of mice via puncture of the cisterna magna. This inoculation causes
the rapid influx of neutrophils from blood, leading to pathological
changes that closely mimic those of human pneumococcal
meningitis [7,15]. Despite this neutrophil recruitment, the host
defence inside the CNS is unable to eradicate the pathogen, without
antibiotic therapy meningitis almost invariably causes the death of
the animals [16] (as is the case in human meningitis [17]). To rescue
the mice and to study the resolution phase of the inflammation, mice
have to be treated with antibiotics (beginning in this model usually
at 24 h post infection). This treatment results in near-complete
killing of the bacteria as very few bacteria can be cultured from CSF
or brain tissue within 24 h after application of antibiotics [18].
Following application of the antibiotic, the inflammation begins to
resolve and apoptosis of neutrophils can be readily observed in situ
and this apoptosis peaks at 24 h after initiation of treatment (i. e. at
48 h post-infection) [15]. We used this mouse model to analyse the
contribution of apoptosis to the resolution of inflammation. Wt mice
were compared to vav-bcl-2 transgenic mice. These mice express
human Bcl-2 in all haematopoietic lineages including neutrophils
[19]. Neutrophils isolated from the bone marrow of these mice have
been shown to be protected from spontaneous apoptosis in vitro [13].
Upon intracisternal injection, both wt and Bcl-2 transgenic mice
developed fulminant disease. At 24 h after inoculation, all infected
mice presented clinical signs of severe illness such as reduced
vigilance, impaired motor function, weight loss and hypothermia,
irrespective of their genotype. No differences were seen at 24 h
between the two mouse strains with regard to meningitis-
associated intracranial complications (e.g. blood-brain barrier
breakdown, see below), CNS inflammation (as indicated by
cellular infiltrate and high levels of IL-1b and G-CSF, Fig. 1A–
C) and bacterial outgrowth from the CNS (6.4+/20.3 log cfu/ml
cerebellar lysate in wt mice vs. 6.4+/20.2 log cfu/ml in Bcl-2
transgenic mice). In pneumococcal meningitis, neutrophils are
unable to control bacterial replication and bacterial titres in the
CNS are therefore independent of neutrophil numbers, even when
neutrophils are depleted (Fig. S2D). There was no difference in
CSF leucocyte and neutrophil numbers between the mouse strains
(Fig. 1A; absolute numbers of neutrophils were 10,12265,763
(mean/SD of 6 mice) in wt and 11,47166,036 in Bcl-2 transgenic
mice) prior to antibiotic treatment. Following treatment there was
a massive drop in CSF leukocyte counts in wt mice but this drop
was strongly reduced in Bcl-2-transgenic mice, resulting in about 5
times more leukocytes in the CSF compared to wt mice at 72 h
after infection (Fig. 1A). This indicates that apoptosis is essential
for the reduction in CSF leukocyte counts as observed upon
successful antibiotic therapy; if apoptosis is inhibited the CSF
leukocyte numbers will stay up (percentages of apoptotic
leukocytes in wt vs. Bcl-2 transgenic mice at 24 h after initiation
of antibiotic therapy – when started at 18 hours after infection
were: 13.7+/21.5% vs. 3.7+/21.5%). Reduced neutrophil
apoptosis thus leads to a prolonged presence of neutrophils at
the site of inflammation in this model of meningitis.
To assess whether this prolonged presence of neutrophils
affected the course of inflammation and disease, we measured
disease severity and parameters of tissue damage. Significantly
increased levels of IL-1b, IL-1 receptor antagonist (IL-1ra) and G-
CSF but not IL-6 were detected in the brains of Bcl-2-transgenic
Author Summary
Infections are typically accompanied by inflammation and
the presence of leucocytes at the infected site. Especially in
pyogenic (pus generating) infections, neutrophils are the
main leukocytes that arrive and that combat the infection.
When the bacteria have been killed, the inflammation also
has to be resolved, and this resolution involves the death
of the neutrophils through the process of apoptosis.
Although we know that neutrophils eventually die through
apoptosis, the connection between neutrophil apoptosis
and inflammation in bacterial infections has not been
clear. In meningitis, bacteria gain access to the space
surrounding the brain, multiply and cause inflammation.
Despite antibiotic therapy, human pneumococcal menin-
gitis often causes brain damage and death of the patient.
We show here that the experimental inhibition of
neutrophil apoptosis leads to much more severe clinical
disease in a mouse model of bacterial (pneumococcal)
meningitis. This was due to a prolonged inflammatory
activity of the neutrophils. Experimental induction of
neutrophil apoptosis in mice that had been infected and
treated with antibiotics (mimicking human meningitis)
improved the clinical condition and accelerated recovery.
Experimental manipulation of neutrophil apoptosis can
therefore be beneficial in acute inflammation.
Neutrophil Death in Meningitis
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mice as compared to wt mice at 72 h (about 4 times as high,
Fig. 1B,C,E,F), suggesting that neutrophils were not only present
but also continued with their pro-inflammatory functions. We
have previously shown that the loss of caspase-1 (which is required
for the release of mature IL-1b) in mice alleviates inflammation
[20] and this prolonged production of this cytokine may therefore
contribute to the hyperinflammatory phenotype. Levels of IL-1
receptor antagonist also remained high in Bcl-2 transgenic animals
as compared to wt animals while levels of IL-6 dropped in both
strains of mice (Fig. 1E,F). These data are indicative of a prolonged
pro-inflammatory activity in the brain of Bcl-2 transgenic mice.
Apoptotic neutrophils are taken up by macrophages, and the
uptake of apoptotic cells by macrophages has been suggested to
have anti-inflammatory effects. The two anti-inflammatory
cytokines TGF-b and IL-10 have been found to be secreted by
macrophages that have taken up apoptotic cells and are thought to
be mediators of the anti-inflammation. The persistence of the
infiltrate in Bcl-2 transgenic mice following meningitis in vivo
suggested that neutrophils were not taken up by macrophages, and
this might result in reduced secretion of TGF-b (IL-10 is not
detectable in this model [15]). We therefore measured the levels of
TGF-b in brain homogenate from infected mice. In wt mice, the
levels of TGF-b reached a peak at about 24 h and started to
decline after 48 h; baseline was reached again at about 72 h
(Fig. 1D). In brains from Bcl-2 transgenic mice, this increase in
TGF-b levels was not observed; the concentrations were close to
baseline levels at both 24 h and 72 h (Fig. 1D). A reduced
secretion of TGF-b, a likely consequence of reduced uptake of
apoptotic neutrophils, may therefore contribute to the increased
inflammation in Bcl-2 transgenic animals.
Figure 1. Transgenic Bcl-2 blocks the resolution of inflammation in pneumococcal meningitis. Groups of 7 mice (24 h) and 12 mice
(72 h) were infected with pneumococci and in the case of 72 h analysis treated with antibiotics starting at 24 h. (A) CSF leucocyte counts were
determined in samples obtained by puncture of the cisterna magna by counting in a Fuchs-Rosenthal chamber. Absolute neutrophil counts were
calculated on the basis of these numbers and the relative numbers of neutrophils as assessed by Giemsa staining of CSF smears. These numbers were
10,12265,763 (mean/SD of 6 mice) in wt and 11,47166,036 in Bcl-2 transgenic mice (not significantly different). (B–F) cytokine levels were
determined in brain lysates and are expressed as levels per total protein. (B) Levels of IL-1b, (C) levels of G-CSF; *P,0.05, Bcl-2 transgenic mice
compared to wt mice at 72 h. (D) Levels of active TGF-ß in brain homogenates of wt mice (n = 7 (0 h), 7 (24 h), 12 (48 h), 12 (72 h)) and Bcl-2
transgenic mice (n = 7 (24 h) and n= 9 (72 h)), *P,0.05, (wt mice vs. Bcl-2 transgenic mice). (E) Levels of IL-1 receptor antagonist (IL-1ra; *P,0.05, Bcl-
2 transgenic mice compared to wt mice at 72 h), (F) levels of IL-6.
doi:10.1371/journal.ppat.1000461.g001
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Transgenic Bcl-2 leads to enhanced tissue damage and
exacerbation of meningitis
Strikingly, the continued presence and activity of neutrophils in
Bcl-2 transgenic mice was associated with an aggravation of tissue
damage and with more severe disease. The macroscopic hallmarks
of this disease model are multifocal cortical hemorrhages, which
are found histologically to result from widespread leukocytoclastic
vasculitis, predominantly of small vessels in the brain cortex [21].
More extensive hemorrhages were evident in brain sections in Bcl-
2 transgenic mice, both macroscopically (Fig. 2A) and in tissue
sections (Fig. 2B). Quantitative analysis showed a clear increase in
both number (Fig. 2C) and bleeding area (Fig. 2D) in brains of Bcl-
2 transgenic mice. More severe damage to the integrity of the
blood brain barrier was reflected by the albumin concentrations in
the CNS, which were about 10-fold higher in Bcl-2 transgenic
mice than in wt mice (Fig. 2E). The enhanced bleeding and breach
of the blood brain barrier were accompanied by the accumulation
of inflammatory cells in the CSF-filled ventricular space (Fig. S1A)
and infiltrates of cells positive for the neutrophil marker Gr-1 in
the subarachnoid space and around small blood vessels in the
brain (Fig. S1B). Enumeration of cell populations in the CSF
showed that the difference in cell number between wt and Bcl-2-
transgenic mice were due to increased numbers in neutrophils (Fig.
S2B, isotype controls), suggesting a role of these cells in tissue
damage. Further, comparison of relative cell numbers 24 h after
antibiotic treatment showed that the difference between wt and
Bcl-2 transgenic animals was that more neutrophils and fewer
apoptotic cells were present in the CSF of Bcl-2 transgenic animals
Figure 2. Exacerbation of meningitis-induced intracranial complications in Bcl-2 transgenic mice. Brain sections from wt or Bcl-2
transgenic mice at 72 h post infection were assessed macroscopically (A) or microscopically in H&E stained sections (B). Cortical haemorrhages are
easily visible. (B) The area indicated by an asterisk in the bottom left image is shown at higher magnification on the right. Note the extensive vasculitis
(open arrow) and extravasated erythrocytes (closed arrows) suggesting structural damage of the vessel. (C,D) Enumeration and size of the bleeding
areas detected. (E) Severe damage to the integrity of the blood brain barrier was also reflected by increased albumin concentrations in brain tissue
from Bcl2 mice. *P,0.05, Bcl-2 transgenic mice compared to wt mice at 72 h.
doi:10.1371/journal.ppat.1000461.g002
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(Fig. S2C). This strongly suggested that the difference between the
mouse strains was that neutrophils survived better in Bcl-2
transgenic mice. To test this more directly, wt or Bcl-2 transgenic
animals were depleted of neutrophils by injection of anti-Gr-1
antibody (Fig. S2A). When Bcl-2-transgenic mice depleted of
neutrophils were infected with pneumococci, haemorrhages were
massively reduced (Fig. S2E,F) indicating that the brain tissue
damage indeed depended on neutrophils. Wt mice showed fewer
and much reduced hemorrhages compared to Bcl2-transgenic
mice and depletion of neutrophils in wt mice led to complete
disappearance of cerebral hemorrhages (Fig. S2F).
The histological findings suggested more severe disease in Bcl-2
transgenic mice. Indeed, the clinical scores were significantly
higher in these mice at 72 h than in wt mice (wt 5.3+/22.1; Bcl-2
transgenic 10.5+/24.6; 12 mice in each group, p,0.02). The
outcome of this model can be adjusted by using different
pneumococcal strains and by varying the time of antibiotic
treatment. In the protocol we used here, the model has a near zero
mortality in wt mice, and while all 12 wt mice survived in this
series of experiments, 3 out of 12 Bcl-2 transgenic mice died (a
summary of the survival of mice is given in Fig. S6). Blockade of
apoptosis is thus sufficient to block resolution of the inflammation
that is induced by pyogenic infection.
Bcl-2 rescues neutrophil function in vitro
These results strongly suggested that neutrophils that were
experimentally kept alive by Bcl-2 maintained their inflammatory
function. This would have to mean that neutrophil ‘ageing’ does not
operate as long as the cells are not undergoing apoptosis, i. e. that
ageing was mechanistically identical to apoptosis. We next established
an in vitro system to address the question whether apoptosis is indeed
required to turn off a neutrophil and whether inhibition of apoptosis
can preserve neutrophil function. To block apoptosis, we again chose
the over-expression of Bcl-2. The use of primary neutrophils from
mice can be difficult due to experimental variation and low yield. We
therefore chose a recently described system that allows expansion of
neutrophil progenitor cells and differentiation in vitro. Neutrophil
progenitor cells are immortalised by a fusion protein of the estrogen
receptor and the oncoprotein Hoxb8, allowing unlimited expansion
of these progenitors in the presence of stem cell factor (SCF).
Withdrawal of estrogen turns off Hoxb8, allowing the differentiation
into mature neutrophils in vitro [22].
Progenitor lines were established from wild type (wt) and vav-bcl-
2-transgenic mice. Both lines of progenitors grew equally well in the
presence of estrogen. Withdrawal of estrogen caused differentiation
with indistinguishable kinetics in both lines, as measured by the
appearance of neutrophil morphology and the expression of the
neutrophil marker Gr-1 in the course of several days (Fig. S3).
We tested the anti-apoptotic effect of Bcl-2 against spontaneous
neutrophil apoptosis in two conditions. Neutrophils were differ-
entiated in vitro for five days in the presence of SCF. At day 5 to 6,
wt neutrophils began to undergo spontaneous apoptosis (detected
by staining for annexin V and propidium iodide and by nuclear
morphology) despite the continued presence of SCF, reaching
levels of about 60% apoptotic cells 48 h later (on day 7) (Fig. 3A;
Fig. S4A gives an example of the primary data). When SCF was
washed away on day 5, the apoptotic population was about 50%
on day 6 and 80% on day 7. Under the same conditions, there was
hardly any apoptosis detectable on day 6 in Bcl-2 neutrophils,
while about 15–25% of cells were apoptotic on day 7. Surprisingly,
there was no difference between Bcl-2 neutrophil cultures with and
without SCF (Fig. 3A). This suggests that Bcl-2 was able
completely to block apoptosis due to SCF-withdrawal but that
there was a component of spontaneous apoptosis that was not
inhibited by Bcl-2. Apoptosis was accompanied by rapid activation
of caspase-3 in wt cells, and Bcl-2 blocked this activation (Fig. 3B
and Fig. S4B).
Ageing neutrophils in circulation are phagocytosed and digested
by spleen macrophages. To test whether apoptosis-inhibition by
Bcl-2 also blocked ageing-associated uptake by macrophages,
differentiated neutrophils were labelled with the fluorescent dye
CFSE and incubated with cells from the mouse macrophage line
RAW264.7. As shown in Fig. 3C and Fig. S4C, there was
substantial uptake of wt neutrophils following 16 h of SCF-
withdrawal (Fig. 2C; a large number of cells were apoptotic at this
time, Fig. S4C). In Bcl-2 neutrophils, apoptosis was efficiently
blocked even at 72 h of SCF-withdrawal, and there was very little
uptake of the cells by RAW264.7 macrophages (Fig. S4C). Bcl-2
expression in RAW264.7 cells did not affect phagocytosis (data not
shown). Bcl-2 therefore blocks not only apoptosis but also
macrophage uptake of neutrophils that have gone beyond their
physiological lifespan.
We then used this system to address the question whether
apoptosis was the pivotal mechanism to shut off neutrophils (as
suggested by the in vivo results) or whether ageing neutrophils move
along a program that disables effector function independently of
apoptosis. Neutrophil function was analysed in both wt and Bcl-2-
expressing neutrophils immediately upon full differentiation (day
5). In addition, functional parameters were tested in Bcl-2-
expressing neutrophils on day 7, following SCF-withdrawal on day
5 (at this time point nearly all wt neutrophils cultured without SCF
had died). There was no difference on day 5 between wt and Bcl-2
expressing cells in terms of phagocytosis of FITC-labelled
Streptococcus pneumoniae (pneumococci, Fig. 4A) or GFP-expressing
E. coli bacteria (not shown). Exposure of wt and Bcl-2-expressing
neutrophils to pneumococci or stimulation with PMA resulted in a
very similar level of oxidative burst as measured by the production
of oxygen radicals (Fig. 4B). Furthermore, all three groups of cells
produced similar levels of IL-1b when stimulated with pneumo-
cocci (Fig. 4C) and all thee populations showed similar anti-
bacterial activity when co-incubated with pneumococci in vitro (not
shown). Inhibition of apoptosis by Bcl-2 therefore can maintain
function of neutrophils, suggesting that apoptosis is the crucial
mechanism to turn off these cells. These data are in accordance
with the above in vivo results: apoptosis in a pyogenic infection
occurs when bacteria have been cleared away (for instance
following antibiotic therapy) but if it fails, neutrophils at the site of
infection will maintain inflammation and may do tissue damage.
Treatment with roscovitine induces neutrophil apoptosis
and accelerates recovery
In human meningitis, neurological sequelae despite antibiotic
treatment are common. Brain tissue damage can also be induced
by injection of pneumococcal cell walls, which is reduced when the
infiltration of neutrophils is prevented [6]. Neutrophil activity is
therefore likely to contribute to disease outcome even in the
absence of experimental apoptosis inhibition, and induction of
apoptosis subsequent to or accompanying antibiotic therapy may
be beneficial for meningitis patients. To test this hypothesis more
directly, we used the drug roscovitine to induce apoptosis in
neutrophils. Roscovitine is an inhibitor of cyclin-dependent kinases
that is in clinical use as an anti-cancer agent. A recent study found
that rosocvitine also induces apoptosis in neutrophils, and
roscovitine-treatment improved disease in mouse models of sterile
inflammation [12]. We found that roscovitine induced apoptosis in
neutrophils differentiated from precursors. Apoptosis was imple-
mented by the mitochondrial pathway since it was blocked by Bcl-
2 (Fig. S5).
Neutrophil Death in Meningitis
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To test for apoptosis induction by roscovitine and its
consequences in vivo, we used a different, more virulent strain of
S. pneumoniae (D39, serogroup 2). In experiments with this strain, 4
out of 11 wt mice and 9 out of 12 Bcl-2-transgenic mice died
despite treatment after 24 h (Fig. S6B). This result in wt mice is a
good approximation of the lethality of human pneumococcal
meningitis. We first tested for the effect of roscovitine on the CSF
infiltrate. Wild type mice were infected and treated with antibiotics
at 18 h (the earlier treatment was chosen to keep the point of
analysis at 24 h; this change also resulted in higher number of
mice surviving, see below). One group of mice received roscovitine
at the same time point, the other one vehicle (DMSO). As shown
in Fig. 5A, roscovitine treatment significantly reduced CSF
leucocyte counts as early as 24 h post infection, and a difference
was still detectable at 72 h. Analysis of cell composition in CSF in
these mice showed enhanced relative numbers of lymphocytes
following antibiotic treatment (Fig. 5B). Clearly increased numbers
of apoptotic neutrophils, identified by their nuclear pyknosis and
karyrhexis were seen in the CSF of roscovitine treated mice
(Fig. 5C). Combined treatment with antibiotics and roscovitine
thus induces apoptosis in situ and very likely by this mechanism
reduces the absolute number of neutrophils in the CSF.
When the effect of roscovitine treatment on disease severity was
analysed, a profound beneficial effect was seen. Roscovitine
reduced number and extent of detectable haemorrhagic events
(Fig. 6A,B). Roscovitine significantly improved recovery when
mice were compared to groups that had only received antibiotic
treatment, as assessed by measuring body temperature (Fig. 6C),
physical activity (Fig. 6D) and clinical scores (Fig. 6E). Of the 11
animals treated in each group, 5 died in the group treated with
antibiotics plus vehicle while 2 died upon treatment with
antibiotics plus roscovitine (Fig. S6C). Roscovitine treatment
further led to slightly reduced cerebellar bacterial titres (2.1+/
20.28 vs. 1.74+/20.69 log cfu/cerebellum; roscovitine/ceftria-
xone vs. vehicle/ceftriaxone at 72 h, not significant). Experimental
induction of apoptosis in neutrophils can therefore, in combination
with antibiotic therapy, correlate with a reduction in tissue damage
and disease severity in an acute pyogenic infection.
Discussion
Our results show that experimental inhibition of apoptosis can
exacerbate a pyogenic infection while induction of apoptosis in
neutrophils in vivo can accelerate recovery from meningitis in mice
Figure 3. Overexpression of Bcl-2 protects neutrophils from apoptosis and removal by macrophages. (A) wt or Bcl-2-overexpressing
neutrophils differentiated for 5 days were in addition cultured for 24 or 48 hours in the presence or absence of SCF. Cells were then stained with
AnnexinV-FITC and propidium iodide (PI) and analysed by flow cytometry. Bars/error bars indicate mean/SEM of five independent experiments. (B)
Neutrophils differentiated for 5 days were cultured for 8 or 48 hours in the presence or absence of SCF, followed by staining for active caspase-3.
Error bars show the SEM of three independent experiments. (C) Neutrophils differentiated for 5 days were cultured in the absence of SCF for the
indicated periods of time and stained with AnnexinV-PI or CFSE. Green-fluorescent (CFSE-stained) neutrophils were then added to cultures of RAW
macrophages stained with the red dye PKH26 (ratio neutrophil:macrophages, 5:1). After 4 h of co-incubation, cultures were analysed by flow
cytometric analysis. The proportion of phagocytic cells within the macrophage population is shown for wt or Bcl-2-expressing neutrophils at various
time points. No double-positive cells were observed when reactions were carried out at 4uC (data not shown). Data are mean/SEM from 3
independent experiments.
doi:10.1371/journal.ppat.1000461.g003
Neutrophil Death in Meningitis
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Figure 4. Overexpression of Bcl-2 preserves neutrophil effector functions upon SCF withdrawal. Effector functions of wt or Bcl-2-
overexpressing neutrophils differentiated for 5 days were compared with that of Bcl-2 neutrophils differentiated for 5 days and then cultured in the
absence of SCF for 48 hours. In all experiments Streptococcus pneumoniae and neutrophils were co-incubated at a ratio of 100:1. (A) Phagocytic
uptake of FITC-labelled pneumococci was analysed by flow cytometry after 1 hour co-incubation. Very similar results were seen in 3 independent
experiments. (B) Production of reactive oxygen species was measured by the capacity of neutrophils to oxidise dihydrorhodamine. Cells were
incubated for one hour with pneumococci (bold line) or with PMA (5 mg/ml, dotted line). Unstimulated cells are shown as shaded histogram. Very
similar results were seen in 3 independent experiments. (C) Secretion of IL-1b was measured in supernatants of neutrophils stimulated with
pneumococci for 8 hours. Data are mean/SEM of four independent experiments.
doi:10.1371/journal.ppat.1000461.g004
Neutrophil Death in Meningitis
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following antibiotic therapy. Functional in vitro analysis further
demonstrates that apoptosis is the critical event in terminating
neutrophil function, since Bcl-2-overexpressing neutrophils re-
tained an unaltered capacity to phagocytose, to produce oxygen
radicals and to secrete IL-1b. These data show that the body’s
innate immune system has to be tightly controlled to contain
inflammation in bacterial infections and identify the apoptosis
apparatus as a potential therapeutic target.
Apoptosis is the regular fate of neutrophils and apoptotic
neutrophils are disposed of by macrophage-mediated phagocyto-
sis. In neutrophils from Bcl-2-transgenic mice, apoptosis was
profoundly inhibited and there was no uptake of Bcl-2-overex-
pressing, non-apoptotic neutrophils upon prolonged culture.
Indeed, neutrophils kept alive by transgenic Bcl-2 maintained
their full effector function in all tests we used at a time when almost
all wt cells had died. This strongly suggests that, at least in vitro,
there is no mechanism in place other than apoptosis that would
shut off neutrophil effector function; the process of neutrophil
ageing is therefore probably identical with the initiation of
apoptosis.
It is clear that the end of an immune response has to be tailored
to anti-infectious requirements; both too long and too short
immune reactions might have negative effects on the organism. In
the adaptive immune system, especially in T cells, the termination
of the reaction is associated with massive cell death. The primary
reason for this cell death may be the reduction of clone size that is
necessary because of the massive expansion of T cells at earlier
stages of the infection, but it is likely also required to reduce the
likelihood of autoimmunity and immunopathology. The experi-
mental reduction of T cell apoptosis, such as in mice deficient for
the pro-apoptotic protein Bim can preserve T cell function [23,24]
and causes albeit relatively subtle autoimmunity [25]. In T cells
the prevention of hyperinflammation may thus rely not only on
apoptosis but also on the necessity of antigen-presence for T cell
activity. It is even necessary to retain a certain number of antigen-
specific T cells as memory cells, which will resume a state of
inactivity but can be quickly re-activated. The situation is different
in neutrophils. These cells are programmed to die at the moment
of differentiation and although certain inflammatory stimuli, both
pathogen and host derived, can prolong the life span of neutrophils
[26], they will eventually all die. It is therefore plausible that
apoptosis is the only necessary safeguard against neutrophil-
mediated hyperinflammation. Circumvention of this safeguard by
Bcl-2 over-expression can thus have the drastic effects we have
observed. It is not clear whether Bcl-2-transgenic neutrophils
actually continuously receive activating stimuli, such as bacterial
Pathogen-Associated Molecular Patterns (PAMPS), or whether the
initial stimulation is sufficient to set them off on the road to a
prolonged inflammation that continues even after the pathogen
has gone. If continuous stimulation occurred, the inflammatory
Figure 5. Reduction of CSF leucocyte count and induction of apoptosis by roscovitine in vivo. Wild type mice were subjected to
pneumococcal meningitis by bacterial injection into the cisterna magna and treated either with a combination of ceftriaxone (100 mg/kg,
intraperitoneally) and roscovitine (50 mg/kg intraperitoneally) or ceftriaxone and the vehicle of roscovitine (PBS+20% DMSO). In the case of the 24 h
experiments (n = 10 per group), treatment was initiated 18 hours after infection, whereas drugs were given at 24 h and 48 h after infection in the
72 h experiments (n = 11 per group). CSF samples were obtained by puncture of the cisterna magna and analyzed for leucocyte counts (A) as well as
the relative proportions of leucocyte subpopulations (B) and apoptotic leucocytes (B,C). (A) Roscovitine treatment significantly reduces CSF leukocyte
counts at both observation times. *P,0.05, roscovitine-treated mice compared to vehicle-treated mice. (B,C) CSF samples from untreated, infected
mice (n = 6) were used as controls to assess the effect of antibiotic therapy on leucocyte differential counts and apoptosis. (B) Roscovitine therapy
increases the proportion of apoptotic leucocytes and decreases the proportion of neutrophils in the CSF. (C) Representative CSF smears of the 24 h
time point are shown. Arrows indicate typically apoptotic leucocyte morphology, showing condensed nuclei (filled arrows) and karyorhexis (open
arrows).
doi:10.1371/journal.ppat.1000461.g005
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activity would have to be below the threshold where new
neutrophils are recruited from the blood (otherwise neutrophils
would keep coming in from the blood in wt mice), but it is
nevertheless possible that levels of inflammatory stimuli are still
present that are sufficient for the stimulation of Bcl-2-transgenic
neutrophils at the site of infection.
Brain damage despite optimal antibiotic therapy is a severe
clinical problem in bacterial meningitis. As shown by earlier work,
activated neutrophils can induce tissue damage, and a contribution
of neutrophil-mediated inflammation to brain injury during
meningitis even in the absence of apoptosis inhibition was likely.
It was recently demonstrated that the depletion of neutrophils
changes the course of disease in a mouse model of pneumococcal
pneumonia [27]. In that model, the depletion of neutrophils
prolonged survival of mice and caused differences in histopatho-
logical presentation of the lungs, also suggesting that a pro-
inflammatory activity of neutrophils contributed to tissue damage.
Neutrophils may therefore make regular contributions to disease
progression, and this may affect inflammation in tissue-specific
ways.
Our data show that roscovitine induces apoptosis in neutrophils
in vivo and has a beneficial effect on recovery from meningitis.
Roscovitine is a clinically used inhibitor of cyclin dependent
kinases (cdk). As neutrophils are not cycling, it is surprising that
Figure 6. Roscovitine reduces brain tissue damage and accelerates recovery following pneumococcal meningitis. (A) Representative
brain sections either obtained from an infected, vehicle-treated or an infected, roscovitine-treated mouse at 72 h after pneumococcal infection are
shown. Numerous hemorrhages are predominantly visible in the cortex of vehicle-treated mice. (A,B) Roscovitine is protective against the
development of cerebral hemorrhages. (B) The bleeding area was measured using digitalized macroscopic images with the help of ImageTool
(UTHSCSA, Texas); *P,0.05, roscovitine-treated mice compared to vehicle-treated mice. The reduction in brain pathology in roscovitine-treated mice
was paralleled by a better recovery from the disease, as evidenced by a better reversal of hypothermia (C), a faster recurrence of motor activity (as
determined in an open field test (D)), and a more pronounced reduction in the clinical score (the maximum score value is 19 and indicates severe
disease and moribund condition whereas a score of 0 is associated with healthy, uninfected mice (E)). *P,0.05, roscovitine-treated mice compared to
vehicle-treated mice. (B–E) n = 6 for mice receiving vehicle and n=9 for roscovitine-treated mice.
doi:10.1371/journal.ppat.1000461.g006
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roscovitine induces apoptosis in neutrophils, and this may be
mediated by other, unknown cellular targets of the drug (or cdks
may fulfil other functions in neutrophils). Apoptosis was blocked
by Bcl-2, demonstrating the involvement of the mitochondrial
apoptosis pathway. In clinical use, roscovitine does not have major
side effects, and its use as an anti-inflammatory drug may therefore
be considered. Most importantly, induction of apoptosis could
improve the outcome of the acute infection, and this strategy could
be important in human inflammatory diseases. As neutrophil
apoptosis can also be prevented by cytokines and by bacterial
components, therapeutic targeting of such stimuli might also be
worth considering.
Apoptotic neutrophil death in situ thus has two anti-inflamma-
tory effects that may be of importance. The obvious, direct effect is
that the cells die and thus stop producing pro-inflammatory
mediators. The second, indirect effect is that the dampening
activity of macrophages that normally results from the uptake of
apoptotic neutrophils is absent. The reduced levels of TGF-b in
the brains of Bcl-2 transgenic mice observed here support this
interpretation.
In conclusion, our data show that inhibition of apoptosis can
preserve neutrophil function, and that this inhibition can promote
prolonged, tissue-damaging inflammation in a pyogenic infection.
Factors affecting the lifespan of neutrophils in inflamed tissue are
therefore promising targets in anti-inflammatory therapy. It could
be speculated that besides the therapeutic induction of apoptosis in
neutrophils to reduce inflammation, approaches aiming at
increased survival of neutrophils may be worth considering in
situations where neutrophil function is compromised.
Materials and Methods
Ethics statement
All animal experiments had been approved by the Regierung
von Oberbayern (Government of Upper Bavaria).
Cell lines and bacteria
Hoxb8 neutrophil progenitors derived from WT and bcl2-
transgenic mice as described in [22] were cultured in Optimem
medium (Invitrogen, Karlsruhe, Germany) supplemented with
10% FCS (PAA, Co¨lbe, Germany), 30 mM b-mercaptoethanol
(Sigma, Munich, Germany), antibiotics (100 IU/ml penicillin G
and 100 IU/ml streptomycin sulfate, Biochrom), 4% supernatant
from stem cell factor (SCF)-producing Chinese Hamster Ovarian
cells, and 1 mM oestrogen (Sigma). The retroviral expression
vectors for HoxB8 and SCF-producing cells were provided my Dr.
Mark Kamps, San Diego. Neutrophil differentiation was induced
by removal of oestrogen, and subsequent culture for 5 days in
medium containing 2% SCF. Murine RAW 264.7 macrophages
were cultured in Very-Low-Endotoxin RPMI 1640 (Biochrom,
Berlin, Germany) supplemented with 10% FCS and antibiotics.
Streptococcus pneumoniae serotype 3 bacteria were grown in Trypti-
case soy yeast extract medium (3% trypticase soy broth, 0.3%
yeast extract) overnight at 37uC. To assess differentiation status,
cells were subjected to cytospin and Giemsa stain or stained with
rabbit anti-Gr1-FITC (1:100, BD Pharmingen, Heidelberg,
Germany) in PBS/0.5% BSA for 30 minutes prior to flow
cytometry analysis with a FACS Calibur (Beckton Dickinson,
Heidelberg, Germany).
Apoptosis assays and uptake of apoptotic neutrophils
For analysis of apoptosis by AnnexinV-PI staining, Hoxb8
neutrophils were differentiated for 5 days, then washed in PBS/
10% FCS with or without SCF (2%), and cultured in the presence
or absence of SCF (2%) for 24 or 48 hours. For induction of
apoptosis by Roscovitin, differentiated neutrophils washed in the
presence of SCF were cultured for 8 or 24 hours with SCF (2%)
plus 25 or 50 mM Roscovitin (Calbiochem). After washing with
AnnexinV-binding buffer (10 mM Hepes, 140 mM NaCl,
2.5 mM CaCl2), cells were incubated with AnnexinV-FITC
(1:50, BD Pharmingen) and propidium iodide (1:500, Sigma) for
20 minutes, followed by flow cytometry analysis. For analysis of
caspase-3 activity, neutrophils differentiated for 5 days and washed
as described above were cultured with or without SCF (2%) for 8
or 48 hours. Cells were washed with PBS, fixed in 3.7%
formaldehyde and permeabilised with 1% Saponin (Sigma).
Staining was performed with rabbit anti-active caspase-3 (Abcam,
Cambridge, UK) in PBS/0.5% BSA for 40 minutes, followed by
secondary donkey anti-rabbit-FITC (Dianova, Hamburg, Ger-
many) for 30 minutes. Neutrophils were analysed by flow
cytometry.
RAW macrophages were stained red with PKH26 according to
the manufacturer’s instructions (Sigma) and seeded overnight into
24-well plates at 26105/well. Neutrophils differentiated for 5 days
were deprived of SCF as described above and cultured for 16, 48,
or 72 hours. Immediately prior to the phagocytosis assay, part of
the neutrophils were stained for AnnexinV-PI as described, while
the remainder was stained green with CSFE (1 mM, Invitrogen) at
37uC for 10 minutes, followed by quenching of unreacted dye in
Optimem medium for 30 minutes. Stained neutrophils were
resuspended in RPMI medium and added to macrophage
monolayers at 16106/well. After 4 hours, cells were detached
with accutase (PAA) and subjected to flow cytometry analysis.
Analysis of neutrophil effector function
Hoxb8 neutrophils were differentiated for 5 days and deprived
of SCF for 48 hours, as described for the apoptosis assays. For
analysis of phagocytic capacity, pneumococci grown overnight
were first washed, stained with 20 mg/ml FITC (Sigma) in
carbonate buffer (0.1 M Na2CO3, pH 9.2) for 1 hour at 37uC,
and the optical density of the suspension at 600 nm was adjusted
to 1.0 after washes with PBS. Four times 105 neutrophils were co-
incubated with pneumococci at a bacteria-to-cell ratio of 100:1 for
1 hour at 37uC while shaking, followed by flow cytometry analysis.
In order to analyse the production of reactive oxygen species,
46105 neutrophils were co-incubated with pneumococci at a
bacteria-to-cell ratio of 100:1 at 37uC while shaking. After
30 minutes, 2 mM dihydrorhodamine (Sigma) was added and
co-incubation was continued for another 30 minutes. Cells were
analysed by flow cytometry. For the measurement of IL-1b
production, 56105 neutrophils were co-incubated with pneumo-
cocci at a bacteria-to-cell ratio of 100:1 in 96-well plates for
8 hours. IL-1b was quantified in supernatants using the Mouse IL-
1b DuoSet ELISA kit (R&D Systems, Wiesbaden, Germany)
according to the manufacturer’s instructions.
Mouse meningitis model
The model used in this study has been described previously
[15,21]. Briefly, male C67BL/6 mice were weighed and clinically
examined. Meningitis was induced by transcutaneous injection of
15 ml of a bacterial suspension containing 107 colony forming units
(cfu) per ml of Streptococcus pneumoniae type 3 into the cisterna magna
under short-term anesthesia with halothane. Twenty-four hours
after infection, mice were evaluated clinically and treated with
ceftriaxone (100 mg/kg intraperitoneally). After 48 hours
(72 hours after infection), mice were again clinically evaluated,
reweighed, and the body temperature was measured via a rectal
probe. Then, mice were anaesthetized with 100 mg/kg ketamine
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and 5 mg/kg xylazine. A catheter was inserted into the cisterna
magna to determine CSF leukocyte counts, as well as relative
proportions of leucocyte subpopulations and apoptotic leucocytes.
Subsequently, blood samples were taken by transcardial puncture.
After deep anesthesia with ketamine, mice were perfused
transcardially with 15 ml of ice-cold phosphate-buffered saline
(PBS) containing 10 U/ml heparin. The brains were removed and
rapidly frozen. In a subset of experiments, mice were processed in
the same way at 24 or 48 hours after infection (time point of
antibiotic therapy in the other groups).
Bacterial titers
Cerebella were dissected and homogenized in sterile saline.
Homogenates were diluted serially in sterile saline, plated on blood
agar plates, and cultured for 24 h at 37uC with 5% CO2.
Determination of the blood–brain barrier integrity
Mouse brain homogenates were examined for diffusion of
albumin using ELISA as described previously [28].
Analysis of cerebral bleeding
Mice brains were cut in a frontal plane into 10 mm thick
sections. Beginning from the anterior parts of the lateral ventricles,
9 serial sections were photographed with a digital camera in
0.3 mm intervals throughout the ventricle system. The areas of the
lateral ventricles and the third ventricle were measured (Image
tool, UTHSCSA, Texas, USA) and the volume of the ventricle size
was estimated (S ventricle area/9 pictures60.3 mm). Haemor-
rhagic spots were counted and the bleeding area was measured
(Image tool, UTHSCSA, Texas, USA). Cryosections of mice
brains were H&E stained. In addition, selected brains were
formaline fixed, paraffin embedded, and sections were stained with
H&E.
Immunohistochemical detection of neutrophils
Ten-mm-thick coronal brain sections containing the lateral
ventricles and hippocampal tissue were stained with a rat anti-
mouse GR-1 monoclonal antibody (RB6-8C5; BD Biosciences,
Erembodegem, Belgium) for evaluation of brain neutrophil
infiltration. After quenching endogenous peroxidase activity with
0.3% methanolic hydrogen peroxide and blockage of non-specific
binding by 10% normal rabbit serum, brain sections were
incubated with the anti-GR-1 antibody diluted 1:10 overnight at
4uC. Labelled cells were visualized using biotinylated rabbit anti-
rat IgG at a 1:200 dilution, followed by horseradish peroxidase-
conjugated streptavidin and then 3,3-diaminobenzidine as a
chromogen (all from Vector Laboratories, Burlingame, USA).
After counterstaining with Mayer’s hematoxylin solution, tissue
sections were imaged at a magnification of 35 using a digital video
camera connected to a PC.
Immunoassays for pro- and anti- inflammatory mediators
IL-1b, G-CSF, IL-6, IL-1 receptor antagonist and immunore-
active TGF-ß were determined using commercially available
ELISA kits (Quantikine Assay kits, R&D Systems GmbH,
Wiesbaden-Nordenstadt, FRG). Frozen brain sections (with a
total thickness of 1.8 mm) were homogenized in lysis buffer, then
centrifuged at 12,000 rpm for 15 min at 4uC, and 50 ml of the
supernatant was used for each determination. Additionally, the
protein concentration of the supernatant was measured using the
Nanoquant assay (Carl Roth GmbH, Karlsruhe, FRG) and
cytokine concentrations are expressed with reference to total
protein concentration.
Depletion of neutrophils
Wt or Bcl-2 transgenic mice were injected intraperitoneally with
250 mg rat anti-mouse GR-1 monoclonal antibody 6 hours before
infection as reported previously [29]. The control group of mice
(n = 4) received intraperitoneal injection of 250 mg purified rat
IgG2b isotype control antibody. Mice were infected and analyzed
as above.
Statistical analysis
The principal statistical test used for comparison of multiple
groups (for example, anti-GR-1-treated Bcl-2 transgenic and wild
type mice as well as their respective isotype antibody-treated
controls) was one-way analysis of variance and Scheffe’s test. In
order to test statistical significance between two groups (for
example, roscovitine- and vehicle-treated wild type mice), we used
unpaired Student’s t test. The statistical difference of mortality was
determined by the Kaplan-Meyer log-rank test. Differences were
considered significant at p,0.05. Data are expressed as mean 6
SD.
Supporting Information
Figure S1 Continued presence of Bcl-2 transgenic neutrophils in
the CNS following pneumococcal infection. (A) H&E stained
sections at 72 h of pneumococcal infection show continued
leucocyte infiltration of the lateral ventricle (open arrow) in
infected Bcl-2 transgenic mice but few cells in the same area in wt
mice. (B) Staining for neutrophils by anti-Gr-1 immunohisto-
chemistry at 72 h post infection shows neutrophil infiltration of the
subarachnoidal space (left, open arrow) and neutrophils in the
proximity of microvessels (right, closed arrow). Very few
neutrophils were seen in wt mice in similar sections at this time
point (not shown).
Found at: doi:10.1371/journal.ppat.1000461.s001 (0.10 MB PDF)
Figure S2 Neutrophil depletion reduces CSF inflammation and
brain tissue injury in wt and Bcl-2 transgenic mice. Bcl-2
transgenic mice (n = 5) and wild type mice (n = 5) were rendered
neutropenic by intraperitoneal injection of 250 mg rat anti-mouse
GR-1 monoclonal antibody 6 hours before infection. The control
Bcl-2 transgenic and wild type mice (n = 5 per group) received
intraperitoneal injection of 250 mg purified rat IgG2b isotype
control antibody. Mice were treated with 100 mg/kg ceftriaxone
18 hours after infection and analyzed 24 hours later. (A) To verify
neutrophil depletion, blood samples were obtained at the time of
sacrifice by cardiac puncture. The total leukocyte count was
determined using blood samples diluted in Turk’s solution counted
in a Neubauer chamber, and differential leukocyte counts were
performed on thin blood smears stained by the May-Gruenwald-
Giemsa method. Anti-Gr-1 treatment resulted in a 93.2% and
92.6% reduction in mean neutrophil counts in Bcl-2 transgenic
and wild type mice compared with the isotype controls. (B,C) CSF
samples were obtained by puncture of the cisterna magna and
analyzed for leucocyte counts (B) as well as the relative proportions
of leucocyte subpopulations and apoptotic leucocytes (C). (B) CSF
leukocyte counts were 84.1 and 78.6% lower in anti-GR1-treated
Bcl-2 transgenic and wild type mice compared to the respective
isotype controls. (C) Differential leukocyte counts revealed
neutrophils as the predominant leukocyte subpopulation at this
disease stage. Overexpression of Bcl-2 in hematopoietic cells
decreased the proportion of apoptotic leucocytes and increased the
proportion of neutrophils in the CSF. (D) Bacterial titres were
determined in cerebellar homogenates serially diluted in sterile
saline and plated on blood agar plates. Bacterial killing in the CNS
was not affected by neutrophil depletion. (E) Representative brain
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sections either obtained from an isotype- or anti-Gr-1 treated Bcl-2
transgenic animal at 42 hours after pneumococcal infection are
shown. Cerebral hemorrhages are clearly visible in the cortex of
the isotype-treated mouse. (F) Hemorrhagic spots were counted
using digitalized macroscopic images using ImageTool
(UTHSCSA, Texas). * P,0.05, compared to isotype-injected
mice using one-way analysis of variance and Scheffe’s test.
Found at: doi:10.1371/journal.ppat.1000461.s002 (0.03 MB PDF)
Figure S3 Differentiation of wt and Bcl-2-expressing neutrophils
from progenitor lines in vitro. Top, wt or Bcl-2-overexpressing
progenitors were cultured in the presence or absence of oestrogen
in the presence of SCF for 5 days. Cells were subjected to Giemsa
stain to reveal their nuclear morphology. Note the typical
segmentation and doughnut shape of mouse neutrophils, Bottom,
differentiation of wt or Bcl-2-transgenic progenitors was induced
by oestrogen withdrawal. Surface expression of the neutrophil
marker Gr-1 was measured by flow cytometry on days 1, 3, and 5.
The reduction in cell size at the later stage of differentiation may
contribute to the slight reduction in Gr-1 expression after day 3.
Found at: doi:10.1371/journal.ppat.1000461.s003 (0.12 MB PDF)
Figure S4 Inhibition of cell death, caspase-activation and
macrophage uptake in neutrophils by Bcl-2 in vitro (A), wt or
Bcl-2-overexpressing neutrophils differentiated for 5 days were in
addition cultured for 24 or 48 hours in the presence or absence of
SCF. Cells were then stained with AnnexinV-FITC and
propidium iodide (PI) and analysed by flow cytometry. Dot blots
show staining of wt (top) or Bcl-2-transgenic (bottom) cells that
were cultured in the presence (left) or absence (right) of SCF. (B)
Neutrophils differentiated for 5 days were cultured for 8 or
48 hours in the presence or absence of SCF, followed by staining
for active caspase-3. (C) Neutrophils differentiated for 5 days were
cultured in the absence of SCF for the indicated periods of time,
and stained with AnnexinV-PI (upper panel) or CFSE. Green-
fluorescent (CFSE-stained) neutrophils were then added to
cultures of RAW macrophages stained with the red dye PKH26
(ratio neutrophil:macrophages, 5:1). After 4 h of co-incubation,
cultures were subjected to flow cytometric analysis. The
phagocytic (green-fluorescent) macrophage population is found
in the upper right gate (lower panel).
Found at: doi:10.1371/journal.ppat.1000461.s004 (0.26 MB PDF)
Figure S5 Roscovitine induces Bcl-2-inhibitable apoptosis in
neutrophils in vitro. Wt or Bcl-2-overexpressing neutrophils
differentiated for 5 days were cultured for 8 or 24 hours in the
presence of SCF and vehicle (DMSO) or 25 or 50 mM roscovitine
(hatched bars). Cells were then stained with AnnexinV-FITC and
propidium iodide (PI) and analysed by flow cytometry. Graphs
show the percentage of AnnexinV-PI double-positive cells. Bars/
error bars indicate mean/SEM of three independent experiments.
Found at: doi:10.1371/journal.ppat.1000461.s005 (0.01 MB PDF)
Figure S6 Survival curves for wild type and Bcl-2 transgenic
mice after intracisternal inoculation with serotype 3 or serotype 2
pneumococci. Death due to meningitis generally occurred within
8 hours after the initiation of antibiotic therapy (which was started
24 hours after infection). (A) Meningitis induced by a serotype 3
pneumococcus (clinical isolate) resulted in a relatively moderate
disease course, as indicated by zero-mortality in wild type mice
(wt). Infection of Bcl-2 transgenic mice (Bcl2) with this strain
resulted in death of 3 of 12 mice. (B) Compared to the serotype 3
strain, infection of wt mice with the D39 strain led to a
significantly higher mortality rate of 36% (p= 0.019). In Bcl-2
transgenic mice, the D39 strain caused death in 9 of 12 animals
(p = 0.082, not significant, compared to wt). (C) Adjuvant therapy
with roscovitine tended to reduce the mortality rate of wt mice
infected with the D39 strain (p = 0.281, not significant, compared
to vehicle-treated wt). The statistical difference of mortality was
determined by the Kaplan-Meyer log-rank test.
Found at: doi:10.1371/journal.ppat.1000461.s006 (0.02 MB PDF)
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